elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35930635-12C3AB7D-0529-4EBE-A24F-86BE01754F9F
Q35930635-12C3AB7D-0529-4EBE-A24F-86BE01754F9F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35930635-12C3AB7D-0529-4EBE-A24F-86BE01754F9F
Second-line salvage chemotherapy for transplant-eligible patients with Hodgkin's lymphoma resistant to platinum-containing first-line salvage chemotherapy
P2860
Q35930635-12C3AB7D-0529-4EBE-A24F-86BE01754F9F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35930635-12C3AB7D-0529-4EBE-A24F-86BE01754F9F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4a698dccc3203a5688f2284adb0fc7b25c09b91c
P2860
Similar response rates and superior early progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplan